ChiCTR2200056655
Untitled Trial
Anlotinib combined with penpulimab in patients with advanced solid tumors: a single-arm, prospective clinical study
The First Affiliated Hospital of Henan University of CM·Phase 2·Chinese Clinical Trial RegistryNot yet recruiting
View on Chinese Clinical Trial Registry →Study focus
- Disease/Condition
- Lung cancer
Sponsor & location
- Primary sponsor
- The First Affiliated Hospital of Henan University of CM
- Funder
- Self-funded
- Location
- China
Timeline & enrollment
- Phase
- Phase 2
- Start date
- N/A
- End date
- Jun 15, 2024
ICD-10 classifications
Carcinoma in situ: Bronchus and lungSecondary malignant neoplasm of lungMalignant neoplasm of bronchus and lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm: Overlapping lesion of bronchus and lung
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2200056655
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2200056655 through Pure Global AI's free database. This Phase 2 trial is sponsored by The First Affiliated Hospital of Henan University of CM and is currently Not yet recruiting. The study focuses on Lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.